Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-022061

President and CEO sold 18,885 shares at $3.27 ($61,726)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
AUERBACH ALAN H President and CEO 2024-07-02 Sale 10b5-1 −18,885 $3.27 $61,726 7,085,435 D
Open-market sales · 18,885 sh · avg $3.27 · $61,726
Loading xslF345X05/rdgdoc.xml…